Loading…
Savara Inc. is projected to rise to $8.18 by 2027, a +30% move from its current price of $6.29. SVRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $6.16 | $6.29 | $6.42 | 0.00% |
| Jul 13 | $6.11 | $6.29 | $6.47 | +0.01% |
| Jul 14 | $6.07 | $6.29 | $6.52 | +0.01% |
| Jul 15 | $6.04 | $6.29 | $6.55 | +0.01% |
| Jul 16 | $6.01 | $6.29 | $6.58 | +0.02% |
| Jul 17 | $5.99 | $6.29 | $6.61 | +0.02% |
| Jul 18 | $5.96 | $6.29 | $6.64 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.96 | $6.29 | $6.64 | +0.02% |
| Week 2 | $5.83 | $6.29 | $6.79 | +0.04% |
| Week 3 | $5.73 | $6.29 | $6.91 | +0.07% |
| Week 4 | $5.65 | $6.30 | $7.01 | +0.09% |
| Week 5 | $5.58 | $6.30 | $7.10 | +0.11% |
| Week 6 | $5.52 | $6.30 | $7.19 | +0.13% |
| Week 7 | $5.46 | $6.30 | $7.26 | +0.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases in the United States. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development for the treatment of autoimmune pulmonary alveolar proteinosis.
Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania. The company operates within the Healthcare sector.
Savara Inc. (SVRA) is trading at $6.22 per share, with a market cap of $1.27B, ranking 2318.
The year-by-year forecast shows a path of steady upside. The Avg price rises from $6.22 in 2026 to $12.70 in 2030, $39.94 in 2040, and $73.08 in 2050. The max prices project to $17.51 in 2030, $62.01 in 2040, and $122.05 in 2050, with cumulative bullish sentiment through the horizon.
The forecast also highlights ROI progression to 104.2 by 2030, 542.2 by 2040, and 1075 by 2050.
A major floor 31.2% below — a decisive break under it would weaken the trend.
The nearest floor, 21.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 14.9% above — clearing it would confirm fresh momentum.
Key SVRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SVRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.22 | Buy | $6.17 | Buy |
| MA 10 | $6.15 | Buy | $6.10 | Buy |
| MA 20 | $5.84 | Buy | $5.90 | Buy |
| MA 50 | $5.41 | Buy | $5.61 | Buy |
| MA 100 | $5.45 | Buy | $5.45 | Buy |
| MA 200 | $5.25 | Buy | $5.09 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.86 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 38.55 | Neutral |
| Williams %R (14) | -50.72 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 4.33 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 49.28 | Neutral |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 0.67 | Buy |
| Ultimate (7,14,28) | 51.80 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 6.28 | Buy |
| ADX (14) | 26.88 | Buy |
| ATR (14) | 0.12 | Info |
The 30-day technical picture is bullish with RSI(14) at 70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.72 | $6.29 | $7.83 | 0% | Neutral | |
| $6.66 | $8.18 | $10.51 | +30% | Bullish | |
| $7.79 | $9.76 | $12.91 | +55% | Bullish | |
| $8.56 | $10.90 | $14.75 | +73% | Bullish | |
| $9.04 | $11.69 | $16.12 | +86% | Bullish | |
| $9.72 | $12.72 | $17.84 | +102% | Bullish | |
| $10.67 | $14.14 | $20.13 | +125% | Bullish | |
| $12.24 | $16.41 | $23.69 | +161% | Bullish | |
| $14.33 | $19.42 | $28.38 | +209% | Bullish | |
| $15.21 | $20.83 | $30.81 | +231% | Bullish | |
| $23.50 | $33.70 | $52.38 | +436% | Bullish | |
| $37.80 | $58.54 | $97.93 | +831% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.72 | $6.29 | $7.49 | +0.00% |
| August 2026 | $5.32 | $6.24 | $7.48 | -0.87% |
| September 2026 | $5.35 | $6.31 | $7.63 | +1.16% |
| October 2026 | $5.45 | $6.45 | $7.86 | +2.31% |
| November 2026 | $5.38 | $6.39 | $7.83 | -0.97% |
| December 2026 | $5.33 | $6.36 | $7.83 | -0.51% |
Click any year to see its month-by-month SVRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SVRA is projected to trade between $4.72 and $7.83, averaging $6.29 — a potential gain of 0% from today's $6.29. A consolidation phase looks the most probable path here.
Savara Inc.'s 2027 outlook centres on $8.18, within a $6.66 to $10.51 range. That is up +30% on the projected 2026 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2028, SVRA could reach as high as $12.91, with a base case around $9.76 and support toward $7.79 — roughly +55% from $6.29. Buyers look set to stay in control over this stretch.
Expect SVRA to range from $8.56 to $14.75 through 2029. The $10.90 average target implies a +73% move from current prices. That is up +12% on the projected 2028 average. Momentum favours further upside here.
The SVRA price prediction for 2030 points to an average of $11.69 (low $9.04, high $16.12) — a potential gain of +86% on today's $6.29. Buyers look set to stay in control over this stretch.
In 2031, SVRA is projected to trade between $9.72 and $17.84, averaging $12.72 — a potential gain of +102% from today's $6.29. That is up +9% on the projected 2030 average. Momentum favours further upside here.
Savara Inc.'s 2032 outlook centres on $14.14, within a $10.67 to $20.13 range. That is up +11% on the projected 2031 average. That marks a +125% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, SVRA could reach as high as $23.69, with a base case around $16.41 and support toward $12.24 — roughly +161% from $6.29. Momentum favours further upside here.
Expect SVRA to range from $14.33 to $28.38 through 2034. The $19.42 average target implies a +209% move from current prices. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The SVRA price prediction for 2035 points to an average of $20.83 (low $15.21, high $30.81) — a potential gain of +231% on today's $6.29. Momentum favours further upside here.
In 2040, SVRA is projected to trade between $23.50 and $52.38, averaging $33.70 — a potential gain of +436% from today's $6.29. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Savara Inc.'s 2050 outlook centres on $58.54, within a $37.80 to $97.93 range. That is up +74% on the projected 2040 average. That marks a +831% change versus current levels. Momentum favours further upside here.
Investing $1,000 in SVRA today (≈ 158.982512 SVRA) could be worth
$9,307.17
+$8,307.17 (+831%) by 2050 · US Dollar
Based on the average projected SVRA price of $58.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SVRAwould be worth at today's price.
$1,000 invested in SVRA on Jul 10, 2025 (≈ 434.782618 SVRA) would be worth
$2,734.78
+$1,734.78 (+173.5%) today · 2.73× · US Dollar
Based on a SVRA entry price of $2.3 vs. today's $6.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.22 | $1,011.25 | +1.1% |
| 1 month ago | $5.09 | $1,235.76 | +23.6% |
| 3 months ago | $5.66 | $1,111.31 | +11.1% |
| 6 months ago | $5.77 | $1,090.12 | +9.0% |
| 1 year ago | $2.3 | $2,734.78 | +173.5% |
| All time (5.0y) ago | $1.51 | $4,165.56 | +316.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SVRA forecast.
Our base-case forecast reaches $13.00 around 2032.
Implied market cap at $13.00: $2.66B
The multi-year forecast shows a bullish path, with an avg price of $12.70 in 2030 and an ROI of 104.2, then $39.94 in 2040 with an ROI of 542.2, and $73.08 in 2050 with an ROI of 1075. These figures indicate strong upside potential over the longer horizon. While the outlook is optimistic, these are estimates and not guarantees and depend on factors beyond the numbers provided.
Tap a question to reveal the answer.
Avg price $12.70, min $9.83, max $17.51; ROI: 104.2; sentiment: BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising avg prices and ROI; 2030 avg $12.70; 2040 avg $39.94; 2050 avg $73.08.
Yes, the max forecast for 2040 is $62.01, with a bullish sentiment and an ROI of 542.2.
Current price $6.22; market cap $1.27B; rank 2318.
RSI(14) is 70, SMA50 is $5.30, SMA200 is $5.18, support $4.93, resistance $6.22; 30-day range from $5.44 to $7.11.
Savara Inc. Community Discussion
0Share your Savara Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.